Butler University

Digital Commons @ Butler University
Undergraduate Honors Thesis Collection

Undergraduate Honors Thesis Collection

5-2021

Investigation of FSHR-1 site of action and signaling initiation at
the C. elegans neuromuscular junction
Alyssa Lynn Ritter

Follow this and additional works at: https://digitalcommons.butler.edu/ugtheses
Part of the Biology Commons

BUTLER UNIVERSITY HONORS PROGRAM
Honors Thesis Certification
Please type all information in this section:

Applicant

Alyssa Lynn Ritter
(Name as it is to appear on diploma)

Thesis title

Investigation of FSHR-1 site of action and signaling initiation
at the C. elegans neuromuscular junction

Intended date of commencement

May, 9th 2021

Read, approved, and signed by:
Thesis adviser(s)

Jennifer R Kowalski

05/04/21
05/04/21

Reader(s)
Certified by
Director, Honors Program

Date

Investigation of FSHR-1 site of action and signaling initiation at the C. elegans
neuromuscular junction

A Thesis
Presented to the Department of Biology
College of Liberal Arts and Sciences
And
The Honors Program
of
Butler University

In Partial Fulfillment
of the Requirements for Graduation Honors

Alyssa Ritter
May 9th, 2021

1

Abstract
Millions of neurons in our bodies relay messages to various organ systems.
Neuronal signaling involves a combination of electrical and chemical signals between
neurons that create responses in the receiving neuron that are either inhibitory or
excitatory. The nervous system relies on the balance between excitatory and inhibitory
signaling (E:I balance) to maintain its function. G protein-coupled receptors (GPCRs) are
cell surface proteins that play critical roles in regulating neuronal signaling by binding
molecules that initiate intracellular relay pathways. One conserved GPCR known as
FSHR-1, homologous to human follicle stimulating hormone (FSH) receptor, regulates
neuromuscular signaling in Caenorhabditis elegans roundworms. The specific location(s)
where fshr-1 is expressed to regulate normal neuromuscular signaling, as well as the
ligand molecule that activates the FSHR-1 receptor signaling, are still unknown.
My first project (Chapter 2) investigates where fshr-1 expression is sufficient to
restore wild type muscle contraction rates to fshr-1-deficient mutants. Based on previous
behavioral and imaging data, I hypothesized that fshr-1 acts in one or more neurons to
promote muscle contraction. To test this hypothesis, I used a thrashing assay to determine
where fshr-1 is sufficient to restore neuromuscular signaling. My results showed that
fshr-1 can act in cholinergic and GABA neurons, as well as in the intestine, to promote
wild type muscle contractions in normal growth conditions. Future experimentation will
be required to see how fshr-1 acts to regulate neuromuscular signaling in diverse
physiologic conditions, as well as in other neuronal subclasses.
My second project (Chapter 3) investigates the relevant molecules that bind
extracellularly to FSHR-1 to help initiate its signaling pathways. Human FSHR,
analogous to C. elegans FSHR-1, is regulated by binding of FSH alpha (α) and beta (β)
2

molecules; however, there are no direct FSH orthologs in the worm. I hypothesized that
FSHR-1 binds one or more extracellular ligands, likely a glycopeptide or neuropeptide,
because such molecules regulate human FSHR and/or control neuromuscular signaling. I
have begun to test this hypothesis by amplifying the extracellular domain (ECD) of the
FSHR-1 receptor in C. elegans and expressing it as a protein in yeast cells. Eventually,
the purified FSHR-1ECD protein will be used to probe a pool of worm proteins and,
using mass spectrometry, identify potential proteins that bind and activate FSHR-1
signaling in the worm.
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Chapter 1: Introduction
Neuronal Signaling and Excitatory to Inhibitory Balance
There are millions of neurons in the human body that are used for communication
by constantly sending and receiving messages to regulate various organ systems. This
type of neuronal signaling occurs at synapses, which are special cellular junctions
between presynaptic “sending” neurons and postsynaptic “receiving” neurons. During
this synaptic transmission, an electrical signal travels through the presynaptic neuron and
initiates the release of chemical messengers, called neurotransmitters, into the synapse, or
the space between the neurons.
Neurotransmitters bind receptors on the surface of the postsynaptic neuron and
create a response in that cell that is either inhibitory or excitatory (Figure 1.1) (Lodish,
et. al., 2000; Ditmann and Kaplan, 2008). An inhibitory response, often initiated by
signaling from GABAergic neurons, can decrease signal propagation within the receiving
cell. In an excitatory response, commonly initiated by cholinergic neurons (ACh), there is
an increase in signal firing in the postsynaptic neuron. The nervous system relies heavily
on controlling the balanced transmission of excitatory and inhibitory signals (E:I balance)
to maintain proper function (Marder and Prinz, 2002). The complexity of the human
nervous system makes it difficult to follow a singular, specific pathway, leading to an
incomplete understanding of the mechanisms controlling E:I balance. However, the
misregulation of the E:I balance has been observed in many neurological and
neurodegenerative diseases (Rubenstein and Merzenich, 2003). Too much of an
inhibitory response, or lack of excitation and slower processing, results from diseases
such as Parkinson’s or Alzheimer’s Disease. In the opposite case, too much excitation
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can lead to seizures or Schizophrenia (Rubenstein and Merzenich, 2003). Understanding
the molecular mechanisms controlling synaptic signaling is important to learning more
about the nervous system function, as well as creating more specific therapeutics for
nervous system diseases.
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Figure 1.1: The synaptic transmission of neurotransmitters. Neurotransmitters
released into the synapse between two neurons can induce excitatory or inhibitory
signaling. Excitatory neurotransmitters lead to increased signaling on the receiving
neuron (red), whereas inhibitory neurotransmitters lead to reduced excitation on the
receiving neuron (blue). The nervous system relies heavily on the E:I balance to maintain
function (Kowalski lab image).
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G protein-coupled receptors regulate E:I Balance
There are over 800 G protein-coupled receptors (GPCRs) in humans that control a
wide range of cellular responses (Fredricksson and Schioth, 2005). GPCRs are activated
by binding extracellular signaling molecules, “ligands”, which include neurotransmitters,
hormones, and neuropeptides in the nervous system (Hanlon and Andrew, 2015; Oldham
and Hamm, 2008). GPCRs are transmembrane receptors that have a region exposed on
the outside of the cell, a region that passes the cellular membrane seven times, and a
region inside of the cell (Figure 1.2). Intracellularly, GPCRs associate with a trimeric Gprotein consisting of three polypeptide subunits, α, β, and γ. Upon activation of the
GPCR via extracellular ligand binding, there are conformational changes in the protein
receptor that relay the signal to the intracellular side of the cell (Oldham and Hamm,
2008). Specifically, the α subunit of the trimeric G protein exchanges GDP for GTP,
which causes dissociation of the β and γ subunits and activation of downstream signaling
pathway(s), including production of second messengers. This ultimately leads to
differential cell behavior, such as downstream neuronal signaling (Hilger et. al., 2018).
Due to the fact that there is an abundance of GPCRs functioning in the nervous
system, there are still many unknown details regarding which GPCRs activate which
specific downstream enzymatic pathways in different types of neurons (Bethke, et. al.,
2012). GPCRs can be effective directly within the cell in which they are located (cell
autonomous) or may have indirect effects in cells nearby where they are expressed (cell
non-autonomous). As an example of autonomous signaling, GPCRs, such as the
metabotropic glutamate receptor, act as autoreceptors on presynaptic neurons, which
allow the neuron to perform synaptic signaling based on internal feedback loops (Huang
10

and Thathiah, 2015). Conversely, the DOP-4 dopamine receptor, a GPCR with cell nonautonomous effects, can act in specific neurons in the worm to signal for neuronal release
of a molecule that supports immune function through its effects on other cells (Cao and
Aballay, 2016). These examples highlight the abilities of GPCRs to function throughout
different organisms, both directly and indirectly. Specific to the nervous system, GPCRs
are able to regulate release of molecules into the synapse of neurons and maintain the
balance of excitatory and inhibitory signaling (Sieburth, et. al., 2005). It is critical to
learn more about GPCR regulation of neuronal signaling in order to develop a better
understanding of neurological disorders and diseases that result from an imbalance of the
E:I signaling.
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Figure 1.2: Diagram of the GPCR structure. The G-protein coupled receptor is a
transmembrane protein that is exposed to both extracellular and intracellular sides of the
membrane. The orange, extracellular domain binds to external ligands. The green
transmembrane portion changes shape to relay signaling from a bound ligand. The dark
blue cytoplasmic domain passes the signal to intracellular proteins that can relay the
signal elsewhere in the system to activate other pathways. G- proteins (α, β, and γ) are
bound to the receptor on the intracellular side. Chapter 3 describes the approach to
amplify the orange extracellular domain to identify potential ligands in a pull-down
experiment.
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C. elegans as a model organism for nervous system signaling
Human nervous systems are very complex with billions of neurons and even more
synapses, making them important, yet challenging, to study and understand. To
investigate the role of GPCRs in E:I balance regulation, the roundworm Caenorhabditis
elegans can be used as a simple genetic system. These roundworms replicate quickly with
a four-day life cycle, possess only 302 neurons, have an entirely mapped genome and
nervous system, and also many available genetic mutants, making them efficient for use
in research. The worms also have similar numbers and types of GPCRs as humans, with
many conserved between the two species. Despite its simplicity, the C. elegans nervous
system is anatomically and physiologically similar to that of humans (Fredricksson and
Schioth, 2005). Like humans, C. elegans have sensory neurons, interneurons, and motor
neurons that allow for simple mechanisms of relaying signals throughout the worm. The
motor neurons synapse onto muscles of the worm’s outer body wall to control muscle
movements. This neuron-muscle synapse is known as the neuromuscular junction (NMJ),
and it is commonly used as a model for studying the E:I balance (Gao and Zhen, 2011).
Neuronal signaling at the worm NMJ directly correlates to muscular contraction, which
can be studied through observable behaviors. Ultimately, these roundworms help us to
learn more about the human nervous system through C. elegans experimentation.
FSHR-1 is a GPCR that regulates E: I Balance in C. elegans
One GPCR that has been shown to be important in regulating E:I balance in C.
elegans is FSHR-1, or follicle stimulating hormone receptor. FSHR-1 is conserved in C.
elegans and is analogous to FSHR in humans. In the worm, FSHR-1 is expressed at high
levels in the intestine and neurons. This allows the receptor to control a variety of
13

responses, including signaling at the neuromuscular junction, as well as responses to
pathogens, oxidative stress resistance, and germline differentiation (Powell et. al., 2009).
It has been observed that the FSHR-1 receptor is required for E:I signaling
balance and muscle contraction in C. elegans (Sieburth et. al., 2005). Animals lacking
expression of the fshr-1 gene have decreased muscle contraction, which appears to
correlate with decreased neurotransmitter release from the presynaptic side of excitatory
motor neurons (Sieburth et. al., 2005; Buckley et. al., in preparation). Further
investigation of this observation found that mutant worm strains without fshr-1 expressed
have an accumulation of synaptic vesicles, marked by the presence of the fluorescently
tagged v-SNARE synaptobrevin (GFP::SNB-1), in cholinergic motor neurons (Sieburth
et. al., 2005). There are specific active zone proteins, such as UNC-10 and SYD-2, that
regulate synapse structure and synaptic vesicle location, and fshr-1 is also required for the
localization of these proteins (Buckley, M. Honors Thesis, 2020). Ultimately, these
defects show that fshr-1 expression is critical for synaptic vesicle protein regulation in its
control of neuromuscular activity and the E:I signaling balance; however, the cells in
which fshr-1 acts to control neuromuscular function, as well as how FSHR-1 regulates
such neuromuscular signaling events, remains unknown.
In the intestine, fshr-1 is understood to be necessary and sufficient at the primary
site of exposure to ingested pathogens to prevent them from getting into intestinal cells
(Powell, et. al., 2009). In fshr-1 mutant experiments, pathogens in the worm are not
discriminated against as quickly as they are in wild type worms. This led to the
conclusion that fshr-1 regulates the expression of immune and stress response genes,
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implying the fshr-1’s role in worm infection and other stressful environments, such as
oxidative stress (Miller et. al., 2015).
In addition to fshr-1’s role in activating the innate immune response, it has also
been proposed that neuronally expressed FSHR-1 is involved in inter-tissue signaling to
promote survival in response to mitochondrial stress at the intestines (Kim and Sieburth,
2018). FSHR-1 appears to have cell non-autonomous effects by controlling the
localization of the lipid kinase signaling molecule, SPHK-1, at the intestinal muscles.
Therefore, it is important to study the role of neuronally expressed FSHR-1 at the
intestines, as well as the role of intestinally expressed FSHR-1, in order to learn if
neuronal FSHR-1 has a cell non-autonomous role (Kim and Sieburth, 2018; Powell, et.
al., 2009). Much is understood about the role of FSHR-1 in intestinal and immunological
function; however, its site of action and required locations for neuromuscular functions
are not known.
FSHR-1 activation ligand(s) are unknown
FSHR, the human structural analog to FSHR-1 in C. elegans, is regulated by
specific glycopeptides called FSH alpha (α) and beta (β) (Chu, et. al., 2010; Chu, et. al.,
2013). FSHR and its FSH ligands have been found in mammalian hippocampal neurons
and spinal cord tissues, but not much is understood about FSHR’s potential neuronal
function in humans (Chu, et. al., 2010; Chu et. al., 2013). FSHR is also involved in
human gonad development and function (Cho et. al., 2007). Despite this understanding,
there is not a strong understanding of the neuronal functions of mammalian FSHR and
there are not analogous glycopeptides in the worm to that of FSH α and β. The
molecule(s) that modulate FSHR-1 receptor activity in any context in the worm are
15

unknown, but FSHR-1 is expressed in multiple tissues, such as the intestine and neurons,
and has been shown to regulate E:I signaling balance (Sieburth, et. al., 2005). It is critical
to learn more about FSHR-1 in C. elegans, as it can ultimately be applied to a greater
understanding of the human nervous system.
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Thesis Statement
Previous research has shown that FSHR-1 is expressed in C. elegans neuronal
cells, along with findings that fshr-1 mutant worms display an accumulation of synaptic
vesicle proteins in cholinergic neurons. These data led me to hypothesize that fshr-1 is
sufficient to act in all neurons to restore normal excitatory and inhibitory balance at the
neuromuscular junction. To test this hypothesis, a thrashing assay was used to observe
the rates of body bends in rescue worms to help me learn where fshr-1 can act in
neuromuscular signaling. I found significant recovery to wild type in the strains with
fshr-1 placed back under its own promoter in all cells, in GABAergic cells, and in
intestinal cells. I also found that the strain with fshr-1 placed back into all cholinergic
cells did not recover to wild type. In Chapter 2, I will discuss my investigation on the
locations where FSHR-1 can control the E:I balance at the C. elegans NMJ. My results
contribute to understanding the locations in the worm where fshr-1 is sufficient to restore
normal muscular contraction.
Based on the abundance of data supporting glycopeptide and neuropeptide
activation of GPCR signaling, and the understanding of FSHαβ ligand for human FSHR,
I hypothesized that the FSHR-1 receptor activity relies on one or more extracellular
ligands, likely a glycopeptide or neuropeptide, in C. elegans. To test this, I amplified the
extracellular domain of FSHR-1, and expressed it in yeast cells, so that it can eventually
be used to probe a pool of worm proteins and identify proteins that bind FSHR-1 using
mass spectrometry. In Chapter 3, I will describe the progress of my biochemical ligand
experiment to identify the molecule(s) that bind to and activate the extracellular side of
the FSHR-1 protein in the C. elegans to initiate downstream signaling pathways. The
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results of this project will ultimately contribute to understanding the FSHR-1 pathway
and how it aids in the regulation of neuromuscular signaling in C. elegans.
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Chapter 2: Introduction to Neuronal Signaling and FSHR-1 biology
Background
C. elegans FSHR-1 regulates the neuromuscular junction to govern the excitatory
and inhibitory signaling in motor neurons that contribute to muscle contraction (Sieburth,
et. al., 2005, Kim and Sieburth 2020, Fredrickson and Schioth, 2005). Additionally,
FSHR-1 regulation of muscle contraction has been related to its control of active zone
proteins that moderate the release of synaptic vesicles from cholinergic motor neurons
(Chapter 1; Buckley et. al., in preparation). However, the specific cells where FSHR-1
acts to control signaling at the neuronal synapses are not yet characterized. Based on our
preliminary data showing FSHR-1 expression in the intestines and the neurons and that
fshr-1 mutants show defects in the regulation of synaptic vesicles and active zone
proteins, I have investigated where fshr-1 is sufficient to regulate the E:I balance at the
neuromuscular junction.
Initial studies on FSHR-1 function at the NMJ utilized aldicarb assays to study the
balance between excitatory, or cholinergic, and inhibitory, or GABAergic, signaling at
the NMJ (Richmond and Jorgensen, 1999). Aldicarb inhibits acetylcholinesterase, which
is the enzyme that breaks acetylcholine, leading to a build-up of acetylcholine at the
synapse (Figure 2.1). This ultimately impacts C. elegans because when the excitatory
neurotransmitter is not broken down, the E:I balance is disrupted causing
hypercontraction of the muscles and paralysis. When there is too much cholinergic or too
little GABAergic signaling, the animals paralyze more quickly than do wild type worms
because the imbalance in the excitatory and inhibitory signaling leads to increased muscle
contractions (aldicarb hypersensitivity). When there is too little cholinergic or too much
GABAergic signaling, the worms are unable to contract due to the high levels of
21

inhibition that create an imbalance of excitatory and inhibitory signaling (aldicarb
resistance) (Mahoney, et. al., 2006).
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Figure 2.1: Synaptic transmission of neurotransmitters in the presence of Aldicarb.
A balance of ACh and GABA neurotransmitter signaling is required for proper nervous
system function. Excitatory neurotransmitters released into the synapse normally induce a
muscle hypercontraction in the receiving postsynaptic muscle cells. During the aldicarb
assay, worms with too much acetylcholine signaling at the synapse, will paralyze more
quickly than wild type worms. Additionally, too much inhibitory neurotransmitter
signaling can result in decreased muscle activity, or aldicarb-resistance, in the
postsynaptic muscle cells (Kowalski lab image).
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In aldicarb assays, fshr-1 mutant strains display quicker rates of paralysis in
comparison to wild type worms (Sieburth, et. al., 2005). Additional aldicarb studies in the
Kowalski lab indicated that the re-expression of fshr-1 under its own promoter, in all
neurons, and in intestinal cells caused similar rates of paralysis to that of wild type
worms. When fshr-1 was re-expressed in GABA neurons, there was a partial recovery to
wild type rate of paralysis. Lastly, when fshr-1 was re-expressed in cholinergic neurons,
there was a hypersensitive reaction to the aldicarb causing the worm to paralyze more
quickly, which was initially attributed to over-expression of the receptor to greater than
endogenous levels. However, fshr-1 may not be necessary in any of these cells, and reexpression at these locations may have been forcing the phenotypic recovery that was
observed (Buckley et. al., in preparation). Therefore, further research is needed to
determine where fshr-1 acts and how it assists neuronal signaling mechanisms.
I used a thrashing assay to learn more about the role of fshr-1 in neuromuscular
signaling in C. elegans. This assay previously allowed for observations of reduced body
bending in fshr-1 mutant strains in comparison to wild type worms (Wei and Kowalski,
2018). In contrast to the aldicarb assay, the thrashing assay examines neuromuscular
activity by counting the number of body bends in different C. elegans mutant strains in
comparison to those of wild type strains (Figure 2.2) (Sieburth, et. al., 2005). The assay
is run using M9 buffer, which, unlike aldicarb, is a simple saline solution that has no
effect on the worm. In the aldicarb assay, too much excitation may cause faster paralysis
and too little excitation may cause slower paralysis (Sun, et. al., 2013); however, in the
thrashing assay, both phenotypes, too little and too much excitation, could cause reduced
rates of thrashing. The two types of assays have different readouts related to paralysis and
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muscle contraction, respectively, so a complete understanding of genetic effects on
neuromuscular signaling is obtained by comparing the results from the individual assays
(Matthews, et. al., 2003).
Based on what is known about FSHR-1 expression in the intestines and the
neurons, along with the effects on synaptic vesicles and active zone proteins in fshr-1
mutants, the goal of my experiment was to investigate where fshr-1 is sufficient to
regulate the E:I balance at the neuromuscular junction in the thrashing assay (Sieburth, et.
al., 2005). I hypothesized that fshr-1 is sufficient to act in all neurons to restore normal
excitatory and inhibitory balance at the neuromuscular junction. I expected pan-neuronal
rescue strain to recover to wild type NMJ thrashing rates and the intestinal fshr-1 rescue
strain to have reduced thrashing rates that are similar to the fshr-1 mutants. In addition, I
expected the rescue strains with fshr-1 expressed only in GABA neurons or cholinergic
(ACh) neurons to give partial rescue if fshr-1 is required in multiple neurons for
neuromuscular signaling.
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Figure 2.2: Thrashing Assays for C. elegans neuromuscular function. This image
displays one complete body bend of a worm in a thrashing assay under normal
conditions. For the experiment, body bends were counted for one minute (body
bends/minute) [Hart ed., 2006; WormAtlas (Altun, ed, et. al 2002-2021) reprinted with
permission February 17, 2021)].
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Materials and Methods
Strains and maintenance
JRK99; kjrEx27 [Punc-17::fshr-1; Pmyo-2::NLS::gfp]; fshr-1(ok778), AU251
agIs35; (Pges-1::fshr-1, Pmyo-2::mCherry); fshr-1(ok778), JRK56; kjrEx15; (Punc30::fshr-1; Pmyo-2::NLS::gfp); fshr-1(ok778), AU209; agEx52 [Pric::19: fshr-1; Pmyo-2nls::cherry]; fshr-1 (ok778), WY335; fdEx41[Pfshr-1::fshr-1::gfp]; fshr-1(ok778), fshr1(ok778), and N2 Wild type worms were grown at 20ºC on NGM agar plates with OP50
E. coli to the young adult stage (Brenner, 1974).
Thrashing Assay
The thrashing assays were performed on 30 young adult C. elegans of each strain.
Individual, young adult C. elegans were first picked onto a clean plate with OP50 and
double blinded to genotype. Then, they were placed on an unspotted NGM agar plate for
1 minute. Next, one worm at a time was moved into a single well on a 96-well plate with
100µl of M9 (22 mM KH2PO4, 42 mM Na2HPO4, 86 mM NaCl) buffer and left to
acclimate for 1 minute. Following acclimation, body bends were recorded for 1 minute
with a clicker. One thrash was represented by represented one full body bend to one side,
and then bending back to the center position (Nawa et. al., 2012; Wei and Kowalski
2018; Figure 2.2). The positive control was the fshr-1 mutant strains, and the negative
control was the N2 wild type. A F-Test of Variance and Test of Normality were
performed on the datasets. The statistical significance of differences between the strains
was determined using an ANOVA factorial analysis, followed by a Tukey post-hoc test
(α < 0.05).
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Results
The thrashing assay has been used repeatedly to assess neuromuscular function
and identify genes involved in neuromuscular signaling (Wei and Kowalski, 2018). My
goal was to use the thrashing assay to test for the percent recovery of neuromuscular
function of fshr-1 mutant C. elegans strains expressing fshr-1 at different locations in
comparison to N2 wild type strains. In these animals, fshr-1 was placed back under the
control of a cell-type specific promoter (pan-neuronal, intestinal, cholinergic neurons,
GABA neurons, and the endogenous fshr-1 promoter). The promoter of a gene is where
transcription factors bind to start the process of reading DNA into RNA, which is known
as transcription. I observed the impact on thrashing rates of the worm when fshr-1 is
expressed only in specific cells.
In my initial experiment, fshr-1 mutants were tested for general neuromuscular
function by measuring the number of body bends per minute (Nawa, et. al., 2012). This
allowed me to compare the fshr-1 mutants to the wild type C. elegans thrashing and
observe the decrease in thrashes in the fshr-1 mutant strain by an average of 18.3%,
which was in line with previously published results (Figure 2.3A, ANOVA, Tukey’s post
hoc, **p< 0.001) (Wei and Kowalski, 2018).
As expected, the worms with fshr-1 placed back under its own promoter (Pfshr-1)
were statistically similar to wild type worm thrashing and decreased from wild type
thrash rate by 3.6% (Figure 2.3B, ANOVA, Tukey’s post hoc, **p < 0.001, WT vs. fshr1 and fshr-1 vs. rescue; n.s., WT vs. rescue). These data show that the rescue strain with
fshr-1 placed back under its own promoter in all cells significantly rescued the rate of
muscular contraction.
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Tests with pan-neuronal, GABA neuron-specific, and intestinal rescue strains
exhibited variable levels of restoration of wild type thrashing behavior. The pan-neuronal
rescue strain (Pric-19) displayed a partial recovery, as it had different rates of thrashing
than both wild type and fshr-1 mutant strains (Figure 2.3C, ANOVA, Tukey’s post hoc,
**p < 0.001, WT vs. fshr-1 and fshr-1 vs. rescue and WT vs. rescue). The GABAergic
neuron-specific rescue strain (Punc-30) displayed a 5% decrease from wild type thrashing
rates but was still significantly significant (Figure 2.3D, ANOVA, Tukey’s post hoc, **p
< 0.001, WT vs. fshr-1 and fshr-1 vs. rescue; *p < 0.05, WT vs. rescue). This was a
stronger rescue than the pan-neuronal strain, but still not complete. Surprisingly, the
intestinal rescue strain (Pges-1), originally observed with the intention of being a
negative control, had a percent mean total thrashes that was 2% less (and not statistically
different) than wild type, meaning that it was sufficient in recovering to wild type
thrashes (Figure 2.3E, ANOVA, Tukey’s post hoc, **p < 0.001, WT vs. fshr-1, fshr-1 vs.
rescue; n.s., WT vs. rescue).
In contrast to all of the other rescue strains, the cholinergic (ACh) neuron-specific
rescue strain (Punc-17) displayed no rescue in the thrashing experiments and had an
average rate of thrashes that was 18% less than wild type C. elegans (Figure 2.3F,
ANOVA, Tukey’s post hoc, **p < 0.001, WT vs. fshr-1 and WT vs. rescue; n.s., fshr-1
vs. rescue).
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Figure 2.3: fshr-1 re-expression in neurons and intestine restores muscle excitation
in thrashing assays. fshr-1 re-expression under its own promoter restores normal body
bends to fshr-1(ok778) mutants (A and B). fshr-1 re-expression under a pan-neuronal
promoter and GABA neuron promoter partially restores normal body bends (C and D,
respectively). fshr-1 re-expression in the intestine fully restores normal body bends (E).
fshr-1 re-expression under cholinergic neuron promoters do not rescue body bending (F).
Means ± s.e.m. shown (n = 30 worms/strain, *p<0.05 vs wild type, **p<0.001 vs wild
type, Tukey’s post-hoc).
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Discussion
The goal of my experiment was to investigate the critical locations for fshr-1
expression to promote muscle excitation to control E:I signaling balance at the C. elegans
neuromuscular junction. My hypothesis that fshr-1 is sufficient in all neurons to restore
normal excitatory and inhibitory balance at the neuromuscular junction was supported
with some, but not all, of the rescue strains used in the experiment. The strains that were
sufficient in complete restoration of thrashing to wild type C. elegans were the ones that
had fshr-1 placed back under its own promoter in all cells and placed back under only
intestinal promoters (Figure 2.3B, E). There was partial recovery in both strains where
fshr-1 was re-expressed in GABA and pan-neuronal cells (Figure 2.3C-D). The strain
with fshr-1 placed back into all cholinergic cells did not show any rescue (Figure 2.3F).
My hypothesis was only partially supported with the thrashing results from the
pan-neuronal and GABAergic rescue assays. These data were surprising because fshr-1
has known effects in neurons and plays a role in normal muscle activity and the balance
of inhibitory and excitatory signaling (Sieburth, et. al., 2005). The fact that there was
only partial recovery has several potential explanations. First, this may suggest that the
overexpression of fshr-1 in these neuronal rescue strains leads to decreased rates of
thrashing due to an inhibition of the normal excitatory and inhibitory balance present in
neuromuscular functioning (Sieburth, et. al., 2005). The overexpression could be related
to the fact that fshr-1 is not normally expressed in these locations or not to the levels
achieved in our re-expression strains, so the worms are experiencing other, nonendogenous FSHR-1 effects in reaction to the new or increased gene expression present
that resulted in decreased thrashing rates. Conversely, there may not have been high
enough expression of fshr-1 at these neuronal locations to completely rescue to wild type.
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Second, it is possible that the fshr-1 promoter is leaky, meaning that it may be intestine
specific, but also has some variable neuronal expression that results in a partially
recovered rate of thrashing. This could possibly point to cell non-autonomous, or intertissue, signaling that FSHR-1 is involved with in C. elegans. Lastly, fshr-1 may need to
be expressed in neurons and some other location in the worm for a complete rescue
through establishing normal E:I signaling balance.
The cholinergic rescue strain was not sufficient in recovering to wild type
thrashing and was statistically similar to the fshr-1 mutant strain, which was not what I
hypothesized. There are several possible explanations for why it was similar to the
mutant strain. These data may indicate the importance of fshr-1 acting in other places of
the worm’s body in order to regulate the E:I balance and allow for normal type rates of
thrashing. Alternatively, the ACh neuron-rescued fshr-1 mutants show increased muscle
contraction (hypersensitivity) in the aldicarb assay (Buckley et. al., in preparation). The
hypersensitive cholinergic strains in the aldicarb assay imply a buildup of acetylcholine at
the synapse that causes paralysis more quickly due to the excessive excitatory signaling.
Therefore, it is possible that the decreased body bending is due to over-excitation of
muscles leading to a level of paralysis that impairs muscle contraction that is observed in
the thrashing assay. The thrashing assay indicated an imbalance in E:I signaling at the
NMJ when fshr-1 is present only in cholinergic cells. The results of both the thrashing
and aldicarb assays are indications of the importance of fshr-1 in cholinergic cells;
however, as noted above, the expression of fshr-1 achieved in these cells may not match
the natural endogenous levels.
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The intestinal strain did not support my hypothesis because, unexpectedly, it did
completely restore muscle contraction in comparison to wild type strains, despite the fact
that it is not a neuronal cell. The intestinal rescue strain and the cholinergic rescue strain
both displayed hypersensitive phenotypes in the aldicarb assay, which led me to predict
that the intestinal strain would not recover in the thrashing assay because the cholinergic
strain did not. fshr-1 expression and action at intestinal promotors displayed a complete
recovery of wild type thrashing, which could indicate cell non-autonomous effects, at the
neuromuscular junction. Similar to the cases of the other re-expression strains, a potential
explanation for the unexpected recovery of the intestinal strain is that there could be an
overexpression effect in the intestine if fshr-1 was forced to be re-expressed at higher
levels than it normally is in the intestinal cells. Therefore, the recovery of thrashing rate
would not be a natural effect of the replacement of fshr-1, but a more forced effect. In
conclusion, the intestinal expression of fshr-1 is sufficient to restore NMJ signaling, but
the intestines may not require fshr-1 for proper muscular regulation to occur in the worm.
Neuronal FSHR-1 was recently shown to participate in inter-tissue signaling that
regulates a mitochondrial protein response upstream of SPHK-1, a sphingosine kinase
(Kim and Sieburth, 2020). Intestinal SPHK-1 promotes survival of the worm under stress
conditions involving mitochondrial DNA damage and impaired oxidative
phosphorylation (Kim and Sieburth, 2020). However, the defects in SPHK-1
mitochondrial localization were restored to wild type levels only when fshr-1 was reexpressed in the neuronal cells, and not with re-expression in the intestine. Therefore,
FSHR-1 is signaling molecules from the neuron that affects where SPHK-1 localizes in
the intestine. This finding supports FSHR-1’s cell non-autonomous regulation, implying
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that the FSHR-1 acting in the neuron can impact other cell tissues, such as the intestine.
Accordingly, the modest rescue of thrashing from FSHR-1 in the neurons and bigger
rescue of intestinal FSHR-1 could be due to a leaky intestinal promoter that is active in
tissues beyond the intestine, or it may be related to intestine-to-neuron inter-tissue
signaling of FSHR-1 that is yet to be investigated.
There are still more strains and locations of fshr-1 re-expression to be tested to
learn more about where it plays a role in neuromuscular signaling. Two possible strains
that could be tested in the thrashing assay are worms that have fshr-1 placed back under a
hypodermal promotor or a M4 neuron promoter. The hypodermal cells secrete the cuticle
(Roberts, et. al., 2003); thus, expression of fshr-1 here should not play a role in
neuromuscular signaling. The hypodermal strain assay will help to determine if fshr-1
rescue strains will all show signs of recovering to wild type, or if some fshr-1 rescue
strains with fshr-1 placed under its promoter in places irrelevant to neuromuscular
signaling will recover. I would expect the new hypodermal fshr-1 strain to display a
decreased rate of thrashes in comparison to wild type thrashing. The worm should not
recover in this case because the hypodermal cells are related to cuticle secretions and are
not known to be involved in neuromuscular function.
M4 neurons are known multifunctional neurons in the C. elegans and are a
location where FSHR-1 is localized (Brockie, et. al., 2001). A colocalization study
performed in the Kowalski lab indicated that FSHR-1 was in pharyngeal neurons in the
head of C. elegans in the same location as M4 pharyngeal motor neurons. M4 neurons aid
in peristaltic muscle contraction in the pharynx and regulation of sensory responses
(Powell, et. al., 2009). The M4 neurons are related to the neuromuscular junction because
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they promote the secretion of neuropeptides and other soluble factors, such as hormones,
that can act on distant neuronal tissues and could potentially regulate some aspects of
neuromuscular signaling (Ramakrishnan and Okkema, 2014). Specifically, I predict that
the re-expression of fshr-1 under the M4 neuron-specific promoter may yield sufficient
recovery of fshr-1 mutants to wild type muscle activity. However, there are still other
potential sites of reported FSHR-1 expression within head neurons that include the I1, I2,
II3, URB, or NSM pharyngeal inter/sensory neurons (Buckley, et. al., in preparation), as
well as PVW, DVB, and CAN neuron types, which all could be considered in future
experiments as well (CenGEN). The thrashing assays performed on fshr-1 mutants reexpressing fshr-1 in M4 neurons, hypodermal cells, and others will help determine if
there is an fshr-1 rescue strain that does not recover to normal rates of body bending.
Additionally, testing fshr-1 mutant worms exposed to oxidative stress conditions
in the thrashing assay could be compared to my current thrashing assay data in order to
observe the role of fshr-1 in cellular stress responses. fshr-1 is known to be involved in
oxidative stress responses and specifically regulates the expression of an oxidative stress
response gene, known as gcs-1 (Miller, et. al., 2015). The rate of fshr-1 mutant body
bending under oxidative stress was shown to decrease in comparison to wild type (Wei
and Kowalski, 2018). Due to the fact that fshr-1 intestinal rescue strains had similar body
bending rates to wild type worms in a thrashing assay and intestinal fshr-1 was previously
described to play an important role in the innate immune defense and detoxification, it
would be helpful to learn what happens to the intestinal rescue strain in a thrashing assay
after being exposed to oxidative stress (Miller, et. al., 2015). Additionally, testing the
other, previously mentioned fshr-1 rescue strains in an oxidative stress induced thrashing
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assay would contribute to the results of what is already known about fshr-1 in C. elegans.
These data would be helpful in understanding the diverse roles of fshr-1 throughout the
worm’s body.
To observe where fshr-1 is not only sufficient, but necessary, for neuromuscular
signaling at specific locations in the worm, a future direction would be to perform cell
type-specific RNA interference (RNAi) knockdown experiments of fshr-1. RNAi
knockdown would allow the expression of fshr-1 at every location in which it is normally
expressed in the worm’s body except for the specific knockdown location (i.e.,
cholinergic neurons, intestinal cells, etc.). This type of experiment is the opposite of a
rescue thrashing assay where fshr-1 is only expressed in one location. If RNAi-subjected
worms showed significantly decreased rates of body bending in a thrashing assay, it
would imply the necessity of fshr-1 at that particular cellular location for neuromuscular
signaling.
Overall, the thrashing assay rescue experiments support that fshr-1 expression in
intestinal cells and GABAergic neurons are largely sufficient to restore neuromuscular
signaling. However, there may be other tissues or locations where FSHR-1 is critical for
control in E:I signaling balance given the partial rescue seen with several of the reexpression strains and the expression of fshr-1 in multiple other neuronal cell types.
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Chapter 3: FSHR-1 Binding Molecule Identification
Background
FSHR-1 is a glycopeptide hormone-binding GPCR. In humans, this family of
GPCRs includes luteinizing hormone receptor (LHR) and thyrotrophin stimulating
hormone receptor (TSHR), in addition to follicle stimulating hormone receptor (FSHR).
These three mammalian receptors play critical roles in development, reproduction, and
metabolism (Rocco and Paluzzi, 2015). In addition, they all have unique, large Nterminal extracellular domains with leucine-rich repeats that allow them to interact with
their respective glycoprotein hormone ligands and initiate a wide array of downstream
signaling pathways (Kudo, et. al., 2000). Although these different receptors have diverse
and characterized pathways in the mammalian body, FSHR-1 is the only ortholog in C.
elegans, and it is not known whether it performs some or all of the functions of the LHR,
TSHR, and FSHR receptors. Therefore, the extent to which these ligand-binding and
downstream signaling interactions are conserved across mammals and C. elegans remains
unknown.
In humans and other mammalian systems, FSHR interacts with follicle
stimulating hormone (FSH). Mammals have a two-ligand protein complex, composed of
FSHα and FSHβ, that binds to FSHR to initiate the signaling relay pathway. Some of the
most familiar functions of the FSH hormone are to promote the upregulation of genes
related to metabolism and gonad function, as well as downregulating tumor suppressing
genes in mammals and other organisms (Zhang, et. al., 2014). The FSHαβ complex was
found to interact with the entire ectodomain of FSHR-1 extracellular domain (FSHR1ECD) through X-ray crystallography studies. FSHR initially recruits the FSH ligand’s
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sulfated tyrosine region that plays an important role for ligand recognition and relaying
signals downstream. Tyrosine binds to the high-affinity domain region of FSHR and
changes the receptors conformation to form a binding pocket. Then, the sulfated tyrosine
inserts into the newly formed pocket and results in FSHR activation of downstream
intracellular events (Jiang, et. al., 2012). Although this is well understood in humans, it is
not known whether this interaction is happening in the same way in C. elegans, as it may
not be a conserved mechanism for FSHR-1 ligands.
Human TSHR also was recently discovered to be activated by a heterodimer
glycoprotein known as GPA2/GPB5 (Rocco and Paluzzi, 2015). This research established
a strong connection between the expression of GPA2/GPB5 in vertebrates and similar
molecules in C. elegans, the glycopeptides, FLR-2 and T23B12.8 (van Sinay, et. al.,
2017). Based on the understanding of TSHR and GPA2/GPB5 binding in humans, we can
study FLR-2 and the gene product of T23B12.8, and their potential binding partners in the
worm. There is no TSHR homolog in the worm, so this could have possible relationships
to FSHR-1 binding interactions and could apply to neuromuscular binding interactions in
the worm.
Investigation of human LHR in comparison to its ortholog in C. elegans, an LGR
(leucine-rich repeat-containing GPCR), showed that the worm LGR may be
constitutively active (Kudo, et. al., 2000). This was suggested because when certain
regions of the worm LGR were expressed in place of the LHR in mammalian embryonic
kidney cells, there were still signs of activation, measured by cyclic AMP (cAMP)
production even in the absence of ligand stimulation (Kudo, et. al., 2000). Thus, it is still
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not clear what molecule activates LHR, or if the receptor is always active until it is
deactivated with a binding molecule.
C. elegans have no identifiable FSH, TSH, or LH ortholog molecules, but there
are several proposed models for potential FSHR-1 activation based on the receptor being
homologous to human FSHR with 50% similarity and 30% identity in protein sequence
components (Kudo, et. al., 2007). One proposed model suggests that FSHR-1 binds to
endogenously produced damage-associated molecular patterns (DAMPs) which can
perceive reactive oxygen species damage and activate FSHR-1 to initiate the innate
immune response system (Miller, et. al., 2015). This prediction related to the recognition
and response of infection may support future investigations of the FSHR-1 ligand.
Outside of FSHR-1 involvement in the immune response, several other hypothesized
potential FSHR-1 binding molecules are related to neuromuscular signaling and the
nervous system. Throughout the C. elegans body, there is modulation of different types
of signaling, such as nociception and pain perception, via neuropeptides and monoamine
neurotransmitters (Mills, et. al., 2011). Neuropeptides and neuromodulatory molecules,
like the monoamines, are known to be involved in GPCR-binding and have control in
neuronal signaling in areas such as the sensory nervous system (Mills, et. al., 2011).
As noted above, there are also alpha (α) and beta (β) glycopeptides to be
considered as potential binding modulators of FSHR-1 based on what we understand
about the conservation between the human and worm receptors. Although there is not a
direct glycopeptide ortholog of human FSH in C. elegans, flr-2 encodes an established
glycoprotein hormone α subunit in the worm that can participate in neuronal control of
the intestines when networked with other flr genes and ghi-1 (Oishi, et. al., 2009). FLR-2
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is a neuronal signaling molecule that interacts with a network to regulate intestinal
processes in the worm (Oishi, et. al., 2009). In general, flr genes act in the intestines and
regulate growth rates and antibacterial defenses, whereas GHI-1 is a protein that is bound
to FLR2. Both these proteins are part of a functional network with glycoprotein hormones
that act in neuronal signaling control of the intestines. flr-2 is a highly expressed gene in
the C. elegans head, pharynx, and tail, and is also homologous to the mammalian GPA2
subunit that interacts with TSHR (Rocco and Paluzzi, 2015). The worm also has an
identified glycoprotein β subunit, encoded by the gene T23B12.8, which is involved in
antibacterial defense with flr-2 (Rocco and Paluzzi, 2015; van Sinay, et. al., 2017). There
are other flr genes that need to be considered as potential FSHR-1 binding molecules
because they could be related to flr-2, the only encoded α glycoprotein hormone subunit
in the worm (Rocco and Paluzzi, 2015). Because FSHR-1’s ligand is not known, I
proposed an unbiased pulldown experiment to identify potential glycopeptides and
neuropeptides that bind to FSHR-1.
I hypothesize FSHR-1 binds one or more extracellular ligands, likely a
glycopeptide or neuropeptide, because such molecules bind human FSHR to control
neuromuscular signaling. The variety of glycopeptides, neuropeptides, and hormone
molecules previously described, along with previous investigation of FSHR-1 acting in
innate immune systems (Miller, et al., 2015), support my unbiased approach of fishing
for endogenous binding molecule(s) to FSHR-1 in the C. elegans.
Specifically, the goal of my experiment was to identify the ligand(s) that could
play a role in the FSHR-1 neuronal signaling pathway by first expressing and isolating
the extracellular part of the C. elegans FSHR-1 (FSHR-1ECD) from yeast (Figure 3.1).
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Figure 3.1: Overview of the Biochemical Pull-down Experiment to identify FSHR1ECD binding partners. This graphical layout is a flow chart that includes every step of
the project, both what has been accomplished, as well as what still needs to be completed.
The worm DNA is light blue in the first step. Next, the amplification and insertion of the
fshr-1ECD-Flag gene (orange) into the yeast expression vector (blue) is shown. The
complete plasmid (blue + orange) was expressed in E. coli bacteria (yellow), and then
purified again before being expressed as a protein in BCY123 yeast cells (dark blue). I
have completed up through this step in my project. The last steps involve separating the
FSHR-1 proteins from yeast cell components, and then completing a pull-down
experiment followed by mass spectrometry to identify bound ligands (green).
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In order to facilitate recognition via antibodies, a FLAG epitope was attached to
the FSHR-1ECD in the initial polymerase chain reaction. The FLAG-tag interaction with
antibodies allowed for the separation of FSHR-1ECD protein from yeast proteins. The
next step with the isolated FSHR-1ECD will be to probe a pool of lysed worm proteins. If
there is binding, mass spectrometry would be used to identify proteins that bind FSHR-1
and are thus candidate regulators. This experiment will help to develop a complete
understanding of FSHR-1 regulation of neuronal signaling in C. elegans by identifying
relevant binding ligands to the FSHR-1 receptor.
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Materials and Methods
PCR and Nested PCR
Following the CloneAmp HiFi PCR Premix Protocol-At-A-Glance protocol, PCR
tubes were prepared with cDNA from N2 wild type C. elegans (1.2µl), 5’
CGTCTCAGATCATGACATGCTCAACATATCGATCGATTC 3’ (Forward primer,
10µM) and 5’ GATCCTCGAGCTACTTGTCGTCATCGTCTTTGTAGTCCA
ATAACATATCCAAAAAATCAATTCCGC 3’ (Reverse primer, 10µM), and the 2X
CloneAmp HiFi PCR Premix that contained buffer, dNTPs, and polymerase enzyme. The
final volume was brought to 25µl by the addition of diH2O (9.8µl). The forward and
reverse primers were designed with unique cut sites, for BamHI and Xho1 enzymes, and
a specific start codon in order to amplify the FSHR-1 extracellular domain from the entire
cDNA template sequence. The PCR reactions were run on a BioRad Thermocycler for 30
cycles (98° for 10 seconds, 55° for 15 seconds, and 72° for 15 seconds [5sec/kb]).
The PCR products were run on a gel to analyze the length of the product to
observe if it was at 1.2kb, the length of the fshr-1ECD. The bands were faint, so the PCR
product was cleaned up (See PCR Product Purification, following section) and then
prepared for a secondary PCR reaction, called a nested PCR. The nested PCR followed
the same protocol as the first round of PCR, just using the purified product of the first
reaction as the template. The products of the nested reaction were then run out on a 0.6%
agarose gel to observe band length. Following the gel electrophoresis, the nested PCR
products were cleaned up, and the concentration of the final nested PCR products were
taken on the NanodropONE Spectrophotometer (Thermo Scientific).
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Gel electrophoresis
A 50mL 1% agarose gel was prepared with one drop of ethidium bromide
(0.625mg/mL, VWR Chemical). The gel was loaded with one lane of 1kb Bullseye ladder
(10µL), and the rest of the lanes were loaded with 5µl of PCR product and 2µl of 1X
loading dye. The gel was run for ~50-60 minutes at ~125-155V. Then, the gel was
imaged on the ProteinSimple Imager using FluorChemQ software, to analyze band length
in kilobases.
PCR Product Purification
PCR products were purified using the Nucleospin PCR Clean-up kit (MacheryNagel). For the final elution step, NE elution buffer was used instead of water, and the
elution was performed over the column twice, 20µL each time.
The Qiagen QIAquick PCR Clean-up was performed to purify the nested PCR
reaction products. In the final step, the DNA was eluted with 30µl of Buffer EB.
Restriction Enzyme Digest
A 40µL yeast cell vector (pJEL-hADAR2) (24ng/µL) was prepared with 3µL of
each enzyme (BamHI and Xho1), along with 4µL of NEB Digestion buffer 3.1 solution.
The nested PCR product from the purification clean-up step was prepared with 5µL of
10X CutSmart buffer solution, 3µL of each enzyme, as well as enough water to equate
the total solution to 50µL (38µL). The reactions were incubated at 37°C for 1 hour and
20 minutes and then stored at -20°C.
Ligation Reaction
The ligation of the digested nested PCR product and digest pJEL yeast vector was
prepared as a 20µL reaction. The experiment consisted of 2µL of the yeast vector
(24ng/µL), 1µL of the PCR insert, 2µL of 10X T4 ligase buffer heated to 37°C, 1µL of
enzyme T4 DNA ligase (NEB), and 14µL of water. The controls were set up as follows:
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Vector+ Ligase-Insert (2µL of yeast vector, 2µL of 10X T4 ligase buffer heated to 37°C,
1µL of ligase, and 15µL of water), Vector-Ligase-Insert (2µL of yeast vector, 2µL of
10X T4 ligase buffer heated to 37°C, and 16µL of water), negative control (2µL of 10X
T4 ligase buffer heated to 37°C and 18µL of water). Once prepared, all four reaction
tubes were left to sit at room temperature for 70 minutes and then stored at -20°C.
Transformation Reaction
The Stellar Competent Cells Protocol was followed to transform the Vector +
Insert into DH5α E. coli bacteria. Four separate microcentrifuge tubes containing 45µL
of the Stellar Competent Cells and 5µL of each of the separate ligation reactions were
placed on ice for 30 minutes, heat shocked for 45 seconds at 42°C, and then placed back
on ice for another 1-2 minutes. Then, 500µL SOC medium was added to the
microcentrifuge tubes and then they were left on a shaker for 1 hour at 225rpm at 37°C.
After the incubation, most of the SOC medium was removed and then the pellet was
resuspended in about 100uL of SOC media left behind. The 100µL solution was then
plated onto 1X LB-agar plates containing ampicillin (100µg/mL) and spread around the
10cm plate with a glass rod. The plates were incubated overnight at 37°C.
Mini-Prep
Single colonies were transferred from the 10cm plate with the +Vector +Ligase
+Insert colonies were prepared in cultures. Three mL LB+Amp cultures were prepared in
Falcon tubes, inoculated with a singular colony, and left to shake overnight at 37°C. The
next day, the High-Speed Plasmid Mini Kit (IBI Scientific) was used to purify the
plasmids out of the colonies. The final step involved eluting from each individual column
with 30µL of water. The reactions were stored at -20°C.
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To ensure that the ligation and transformation were successful, the BamHI/XhoI
restriction digest was repeated on the mini-prep products. The digested product was run
on a 1% agarose gel to observe if there were bands present at 9kb and 1.2kb.
Sequencing
The purified plasmids from the mini-preps were prepared to send to MCLab for
sequencing to confirm insertion of the correct FSHR-1ECD into the yeast vector. Four 60
µL samples of DNA (66.8ng/µL, 64.5ng/µL, 59.1ng/µL, 61.1ng/ µL), along with 80µL of
3 forward primers (5’ CGTCTCAGATCATGACATGCTCAACATATCGATCGATTC
3’, 10µM) and 80µL of one reverse
primer(5’GATCCTCGAGCTACTTGTCGTCATCGTCTTT
GTAGTCCAATAACATATCCAAAAAATCAATTCCGC 3’, 10µM) were sent.
Yeast Transformation and Induction
The complete, sequence-verified 10.2kb FSHR-1ECD containing plasmid,
pJRK103, was transformed into S. cerevisiae BCY123 yeast competent cells. To do this,
3µL of my plasmid was prepared with 50µL of the yeast cells in a sterile cuvette. The
sample was shocked with the electroporator (Bio-Rad; Fungi, S. cerevisiae, 2mm gap),
washed with 100µL of 1M sorbitol, and then the entire solution was pipetted into 1mL of
1M sorbitol on ice. Next, 100µL of this solution was plated on Complete Minimal (CM)
lacking uracil (-URA) plates. The plates were left to incubate at 30°C for 3 days.
After three days, a single colony on the plate was put into 5mL of CM (-URA)
+dextrose media and was incubated at 225rpm for 16 hours at 30°C. Then, the 5mL
culture was transferred into 200mL of CM (-URA) + 3% glycerol/2% lactate. This batch
was put back in the incubator at 30°C at 225rpm for 24 hours. The next day, 20mL of
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20% galactose was added to the 200mL culture and the flask was incubated for another 6
hours (30°C, 225rpm). After 6 hours, 100µL of the solution was put in a microcentrifuge
tube and spun at full speed for 10 seconds. The supernatant was poured off and the pellet
was set aside. The rest of the culture was spun at 5000 x g for 5 minutes on the JA-14
rotor. The pellet was washed and resuspended in ~20mL of 1X PBS. The conical was
spun again at 5000 x g for 5 minutes on the JA-12 rotor. The pellet was stored at -80°C.
Western Blot
The 100µL pellet was resuspended at 95°C for 10 minutes in 75µL of water and
75µL of the 2X-SDS sample buffer. The solution was then loaded into a pre-made BioRad Mini Protean TGX Stain-Free Gel (4-15%), and the Bio-Rad Precision Plus Protein
Kaleidoscope ladder was used. The gel was run at 20mA for 1.5 hours, then transferred to
a nitrocellulose membrane, which was left at 4°C for 2.5 hours at 11V.
The Genie Blotter was dissembled, and the gel was placed in Coomassie stain
(1mg/1mL, 40% methanol, 10% Glacial acetic acid) and put on the rocker for 20 minutes.
Then, the Coomassie stain was removed from the gel and Coomassie destain (10%
Glacial acetic acid, 20% methanol) was added and left overnight. The Coomassie stain
will ensure all protein transferred onto the membrane. The nitrocellulose membrane was
covered in Ponceau Red (Sigma-Aldrich) to stain and rocked for 4 minutes before it was
rinsed with distilled water to expose the red bands that indicate the presence of protein.
Then, the membrane was placed in 30mL of blocking solution (5% milk in 1X TBST)
and rocked for 2 hours at room temperature. The membrane was covered in 8mL of
blocking solution mixed with 1.6µL of M2 anti-flag mouse antibody (Sigma Aldrich,
1:5000) and was left to rock overnight at 4°C.
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The next day, the primary antibody solution was removed, and the membrane was
washed 4 times for 5 minutes each in 1X TBST. Next, 3.2µL of anti-mouse IgG
Horseradish Peroxidase linked whole antibody from sheep (1:5000; GE Healthcare UK
limited was prepared in 16mL of 5% milk solution. The membrane was left on the rocker
for 1 hour at room temperature. After, the 1X TBST washes were repeated and then
500µL of ECL solution (SuperSignal West Femto Max Sensitivity Substrate,
Thermoscientific) was pipetted over the membrane sections for 5 minutes. The membrane
was then imaged on the AlphaImager (ProteinSimple) using the Chemi_Super Protocol,
and results were compared to the Precision Plus Protein Kaleidoscope ladder (Bio-Rad).
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Results
The goal of my experiment was to produce a tagged protein version of the C.
elegans FSHR-1ECD that can be scaled up in yeast cells and eventually be exposed to
worm lysates in order to identify FSHR-1 ligands. Beginning with the polymerase chain
reaction (PCR), the fshr-1ECD domain was amplified from N2 total cDNA. The PCR
was run twice, the second called a “nested PCR,” that used the original PCR reaction
instead of the N2 total cDNA. A nested PCR reduces non-specific binding of DNA pairs
that were not intended to be amplified. This way, if there was any amplification of
unnecessary primer binding sites, it may be refined out of the final PCR product after a
second round of PCR. The concentration of dsDNA after the first PCR was 9.0ng/uL, and
the bands were very faint, but after the nested PCR the dsDNA concentration of the fshr1ECD-flag insert was 181.9ng/uL. The size of the fshr-1ECD was expected to be 1.2kb,
and this was confirmed by running a gel where we saw the bands at ~1.2kb (Figure 3.2).
Both the fshr-1ECD-Flag DNA from the PCR reaction and the yeast vector were
exposed to BamHI and XhoI cutting enzymes in the Restriction Digest. After ligating the
fshr-1ECD-Flag into the yeast vector, the singular plasmids were transformed into E.
coli. Ligation success was confirmed through a diagnostic restriction digest experiment
where I re-exposed the ligated product to BamHI and XhoI. I ran out the product from the
digest on a gel and it resulted in two bands, one at 9kb for the broken yeast vector and
one at ~1.2kb for the fshr-1ECD-Flag insert (Figure 3.3). The samples that were
confirmed to be correct from the gel were sent for sequencing.
The sequence results were successful, as we had no mutations between 800-2206
base pairs in the plasmid, which is where the FSHR-1ECD insert is located. This allowed
us to transform the plasmid into BCY123 yeast cells via electroporation. The yeast cells
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were grown on plates without uracil; this selects for only yeast cells containing our
plasmid. The culture was successful, as our FSHR-1ECD containing plasmid sample had
a similar amount of growth to the positive control. The negative control had one colony
of contamination, but not significant (Figure 3.4).
A Western Blot was used to confirm FSHR-1ECD protein expression in the yeast
cells once they were scaled up in the yeast transformation and induction. The Western
Blot revealed a protein around 55-60kDa in size, and we estimated the FSHR-1ECD-3X
Flag to be about 50.2kDa; therefore, the protein ran close to, although slightly bigger,
than we expected (Figure 3.5).
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Figure 3.2: Confirmation of fshr-1ECD amplification. The gel showed faint bands
near 1.2kb, which is the desired length of the fshr-1ECD insert that was amplified in the
PCR reaction. The ladder used was a 1kb Bullseye ladder (Midsci) (Image taken on
1/28/21).
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Figure 3.3: Diagnostic Restriction Digest as a confirmation of the ligation of fshr1ECD into the pJEL-hADAR2 yeast vector. This restriction digest was performed on
the ligation of the fshr-1ECD dsDNA with the pJEL-hADAR2 yeast vector. The digest
re-cut the fshr-1 product and vector apart. The digested sample was run out on a gel, and
bands were observed at 9kb and near 1.2kb, as expected, knowing that the fshr-1ECD is
1.2kb in length and the yeast vector is 9kb. A 1kb ladder was used (Image taken on
2/21/21).
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fshr-1ECD plasmid

pJEL-hADAR2-RD-JM

Negative control

Figure 3.4: Transformation of the FSHR-1ECD containing plasmid into BCY123
yeast cells. The plasmid samples were electroporated into the yeast cells. After a sorbitol
wash, the final solution was plated onto CM -uracil plates and left to incubate at 30°C for
3 days. The plate on the far left is my FSHR-1ECD plasmid sample, the middle plate is
the positive control (pJEL-hADAR2-RD-JM), and the right plate is the negative control
(water + yeast cells) (Images taken 3/13/21).
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Figure 3.5: Western Blot results of FSHR-1ECD-3xFLAG protein expression in
yeast. The image shows protein expression of the FSHR-1ECD on the nitrocellulose
membrane, which was expected to be around 50.2kDa. An anti-Flag M2 antibody was
used in the Western Blot at a 1:1000 dilution. 30µL and 15µL represent the amount of
prepared lysate loaded into the Mini Protean TGX Stain Free 4-15% gel. The actual
expression was around 57kDa based on comparison to a Precision Plus Protein
Kaleidoscope ladder (Image taken on 3/25/21).
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Discussion
The goal of my experiment was to amplify fshr-1ECD and eventually express it as
a Flag-tagged protein so that I could identify potential FSHR-1 binding molecule(s). Thus
far, I have expressed FSHR-1ECD in BCY123 yeast cells (Figure 3.2). In order to finish
the experiment, the FSHR-1ECD will need to be purified and separated from yeast
proteins, and then be exposed to a pool of worm lysates where it can hopefully interact
with its normal binding molecules. However, there may be some non-specific interactions
that will need to be eliminated by comparisons to an IP with just the beads to see what
binds to them alone. Then, any bound molecules not eliminated by this control IP will be
identified from the mass spectrometry data.
Following the detection of binding molecule(s) of the FSHR-1ECD receptor, it
would be important to observe if that ligand has direct effects in the FSHR-1 signaling
pathway at the worm NMJ. Due to the fact that my IP experiment was unbiased, the
molecule that results from the mass spectroscopy may not be critical for neuromuscular
signaling. This could be tested by knocking out the gene that produces the molecule in
question in the worm, leaving the worm without the suspected FSHR-1 binding ligand.
Using this mutant C. elegans, we could see if there was still normal rates of neuron
signaling or if signaling was inhibited. This could be observed by analyzing the rate of
body bends in a thrashing assay, similar to my first project with the worms missing
FSHR-1 (Chapter 2). This time, if we knock down the putative FSHR-1 binding ligand
and observe the same rates of signaling as wild type worms, then we can conclude that
the molecule we knocked out would not be necessary for FSHR-1 signaling. However, if
this molecule knockdown caused the worms to show decreased rates of thrashing, then
this would suggest that the pull-down experiment detected a ligand that is necessary for
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signaling to occur at the C. elegans neuromuscular junction. The alternative reason would
be that the FSHR-1 receptor is constitutively active without the ligand present, and that
the ligand actually works to turn off the receptor. This could be related to what was
learned about the constant activity in worm LGR receptors expressed in mammalian cells
(Kudo, et. al., 2000). If the receptor was constitutively active and the ligand was knocked
down in the worm, I would expect to see wildtype rates of body bending in the thrashing
assay, as there would be no “off” mechanism for the receptor. To test the overall pathway
composition, we would also need to observe the effects on neuronal signaling in a double
mutant strain that knocks out both the receptor and the newly found ligand. If the ligand
and receptor are acting directly in the same pathway, then this phenotype should appear
to be similar to individual mutants knockdowns of the ligand or receptor. However, if the
ligand and receptor were not acting in the same pathway, then there would be an additive
phenotype of the double mutant that would be worse than either of the individual mutant
knockdowns.
Additionally, a way to observe if the sites on the FSHR-1 receptor are required for
neuronal signaling in vivo at the worm NMJ would be to mutate the area of the gene(s)
encoding the specific ligand binding locations on the receptor using clustered regularly
interspaced short palindromic repeats (CRISPR). CRISPR is a type of gene editing that
allows researchers to directly mutate a cell’s, or organism’s, genome without adding in
extra genes. The worm with CRISPR-deleted FSHR-1 ligand binding site(s) could be
observed in a thrashing assay, and the results of the mutant worms’ body bends could be
compared to wild type body bending rates, as well as to body bending rates of worms
with either knocked-down ligands or knocked down receptors. I would expect to see a
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decrease in body bending for the ligand binding site mutants in comparison to wild type
worms if that binding site is required in vivo for FSHR-1 activity at the NMJ.
Additionally, I would expect the both the binding site mutant worms and the entire
receptor mutant worms to display similarly decreased rates of body bending. This would
imply that the ligand and receptor have a unique interaction that is required for FSHR-1
regulation of NMJ signaling and would further support the results of my original
pulldown experiment. However, if there are other types of signaling at the NMJ that
permit normal muscle contraction, or multiple binding ligands, we will observe a wild
type phenotype in the thrashing assays of these mutant strains, suggesting the FSHR-1
binding site or pulled-down ligand(s) are not necessary for neuronal signaling.
Based on the results of the CRISPR experiment, we can make comparisons
between the human and C. elegans receptors in hopes to establish a more complete
understanding of FSHR-1 regulation of neuronal signaling as it relates to relevant bound
ligands and normal functioning in vivo. If there was a small amino acid sequence
difference between human and C. elegans receptors, it could play a role in regulating the
ability of the receptor to initiate and control neuronal signaling; however, this effect may
not make a significant, observable difference. I could test this by using CRISPR to edit a
small sequence of amino acids in the region of the fshr-1 gene encoding the C. elegans
FSHR-1 receptor to model the amino acids on the human FSHR receptor. I would target
the region identified as the site required for neuronal signaling on the FSHR-1 receptor in
the previously mentioned experiment. This could produce a mutation in the worm’s
normal receptor, leading to less activation, and may decrease the rate of neuromuscular
signaling in comparison to wild type (observed in a thrashing assay). However, if there is
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no change in the rate of body bending, this could suggest that ligand binding in C.
elegans is needed to turn off the receptor, meaning that it is constitutively active, or that
the mutated sequence had no role in ligand activation in the worm receptor.
My current biochemical pull-down experiment, in addition to the proposed future
directions, can help us to learn more about the activation of C. elegans FSHR-1 and about
the structure of the receptor itself. This information can be compared to what is known
about human nervous system signaling and FSHR, which can then be applied on a
broader scale to understanding neurological human disorders, such as Parkinson’s
disease, Alzheimer’s disease, and Schizophrenia (Heng, et al., 2013).
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Chapter 4: FSHR-1 Signaling Conclusions
The goal of my study was to learn more about FSHR-1 location of action and
functional role in C. elegans. Specifically, I investigated where fshr-1 expression is
sufficient to restore normal neuromuscular signaling to fshr-1 loss-of-function mutant C.
elegans and what ligand(s) can bind to activate the FSHR-1 receptor. My approach for
assessing neuromuscular signaling was to use a thrashing assay, where I was able to
analyze the rate of worm body bending and correlate it to E:I signaling. Then, to learn
more about the potential binding ligand(s) for FSHR-1, I began a biochemical pulldown
analysis by expressing my fshr-1 gene as protein in yeast cells.
My thrashing assay experiment (Chapter 2) provided data consistent with
previous research, which helped to further explain the role of FSHR-1 as a regulator of
E:I signaling at the neuromuscular junction of C. elegans. The results of my thrashing
assays suggest that mutant worms with fshr-1 rescued under its own promoter or in
intestinal cells display a complete restoration of muscle contraction in comparison to wild
type strains (Figure 2.3). However, other strains showed a partial rescue that could be
due to overexpression of fshr-1 at that particular location, or from neo-morphisms, in
which fshr-1 is acting in a place it normally is not expressed. This suggests fshr-1 may
need to be present in a second area of the C. elegans body for complete restoration of
muscle contraction. It may be working in both intestines and all neurons, or possibly in
two different types of neurons. To test this, one would need to re-express fshr-1 at two
locations instead of just one, and then subject those rescue strains to thrashing assay
experimentation. Additionally, the cholinergic cell rescue may have experienced overexcitation in the E:I balance, which decreased its rate of thrashing (Figure 2.3). Overall,
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the thrashing experiments provided information about where fshr-1 is sufficient to control
neuronal signaling, which is helpful in providing a more complete picture of E:I balance
misregulation in neurological diseases.
The goal of my experiment in Chapter 3 investigated molecules that have the
potential to bind FSHR-1 to control neuronal signaling, as they are still an unknown part
of the FSHR-1 signaling pathway. I hypothesized that FSHR-1 is regulated by binding to
a glycopeptide or neuropeptide ligand in C. elegans. To date, I have successfully
expressed FSHR-1ECD protein in BCY123 yeast cells. The next steps of the project
involve separating the FSHR-1ECD protein from the yeast cell protein remnants so that
we can expose the specific purified FSHR-1ECD protein to C. elegans lysate. The ligand
pull-down experiment will be able to provide information about how the FSHR-1
receptor is activated. Thus far, it is unknown how many ligands can bind to activate
FSHR-1, or if it is constitutively active; therefore, the present unbiased approach is the
best option for the experiment.
Despite the progress made in my investigation, there are still many aspects of
FSHR-1 signaling to be understood. Thus far, we and others have shown that fshr-1 acts
in multiple locations throughout the C. elegans, including the intestines, immune system,
and nervous system, as well as in both normal growth conditions and under physiologic
stressors (Powell, et. al., 2009; Sieburth, et. al., 2005; Miller, et. al., 2015). fshr-1 has
been shown to act in the neuronal-intestinal stress signaling, which has implications that
it acts cell non-autonomously and signals between tissue types to regulate neuromuscular
signaling (Kim and Sieburth, 2018). If fshr-1 is working in other cells to control NMJ
function, it may be due to indirect signaling pathways or release of molecules at sites
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distant from the NMJ that still result in neuromuscular effects. For example, signaling at
pharyngeal neurons may be able to send signals through interneurons to motor neurons,
resulting in a change of E:I balance at the junction where motor neurons synapse with
muscle cells. This also leaves the possibility that there could be multiple types of
signaling pathways regulated by FSHR-1, as well as a variety of binding ligands. If there
were multiple ligands acting, it would be interesting to see where they were localized in
the worm. It is possible that there are different ligands for FSHR-1 at the variety of
locations the receptor is expressed. However, even pulling down one ligand in the
experiment would allow us to learn more about the FSHR-1 signaling pathway by
investigating where that particular ligand is expressed and released to act in the worm.
Despite the conservation of FSHR-1 in C. elegans and FSHR in mammals,
mammals also have other hormone receptors acting in similar pathways to that of FSHR1 in the worms. It will be critical to learn more about how FSHR-1 relates to these
diverse human hormone receptors, such as LHR and TSHR. This could be done by
considering the functions of LHR and TSHR and observing how the same functions are
carried out in fshr-1 mutant worms, or if they are even able to be performed. For
example, LHR is very involved in human reproduction processes, and it would be
interesting to study fshr-1 mutants by observing aspects of their reproductive cycle, rather
than their neuromuscular behavior. Extending research on FSHR-1 into new organ
systems will ultimately help to fully understand the conserved relationships and signaling
mechanisms between the two organisms.
Together, my two projects contribute to the overall understanding of FSHR-1 in
C. elegans. Chapter 2 provided information about where fshr-1 can act to restore
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neuromuscular signaling; however, more experimentation is required to fully understand
where it is necessary for signaling. The experiment in Chapter 3 is intended to result in
the identification of a ligand that activates FSHR-1 neuromuscular signaling pathways.
The data from my thesis contributes to the overall comprehension of FSHR-1 biology and
highlights the importance of FSHR-1 in C. elegans. Learning more about the C. elegans
nervous system and comparing it to analogs in the human system will ultimately help us
better understand human nervous system disorders and allow for new therapies and
treatments to be developed.
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